Icatibant Injection
Overview
- Presentation(s):
-
30 mg/3 mL
30 mg/3 mL
- NDC(s):
-
55150-351-01
55150-351-03
- Reference Listed Drug:
- FIRAZYR® (Icatibant) Injection by TAKEDA PHARMACEUTICALS USA INC
- Therapeutic Class:
- Bradykinin B2 Receptor Antagonist
- Physical Form:
- Solution
Product Information
| NDC | Description | Strength | Concentration | Container Size | Fill Volume | Closure |
|---|---|---|---|---|---|---|
| 55150-351-01 | Single-Dose Prefilled Syringe | 30 mg/3 mL | 10 mg/mL | – | – | – |
Wholesaler Item Numbers
ABC
–Cardinal
–McKesson
–M&D
–Ordering Information
Unit of Sale
1Pack Size
1Case Quantity
24Allergens
| NDC | Description | Strength | Concentration | Container Size | Fill Volume | Closure |
|---|---|---|---|---|---|---|
| 55150-351-03 | Single-Dose Prefilled Syringe | 30 mg/3 mL | 10 mg/mL | – | – | – |
Wholesaler Item Numbers
ABC
–Cardinal
–McKesson
–M&D
–Ordering Information
Unit of Sale
3Pack Size
3Case Quantity
8Allergens
Additional Information
Bioequivalency Rating
APBar Code Type
LinearControlled Substance Class
N/AStorage Requirements:
Store between 2° to 25° C (36° to 77° F). Do not freeze.For Package Inserts, please click on the NDC#
Our products are available from authorized distributors.
For complete ordering information, please contact your local pharmaceutical distributor.
Key
